Side-by-side breakdowns of every treatment path — inpatient vs. outpatient, every medication option, every recovery philosophy — without the clinical distance.
Americans currently living in recovery
You are not alone in this.
Average treatment attempts before sustained sobriety
Persistence is part of the process.
Better outcomes when patients understand their own treatment plan
Which is why you're here.
Here’s what actually happens
Your level of care should match the severity of your dependence, the safety of your home environment, and your daily obligations. Here's how each setting actually differs — not in theory, but in practice.
| Category | Inpatient / ResidentialLive-in treatment | Partial Hospitalization6–8 hrs/day, home nights | Intensive Outpatient3 hrs/day, 3–5x/week | Standard Outpatient1–2 sessions/week |
|---|---|---|---|---|
| Duration | 28–90 days | 2–6 weeks | 8–12 weeks | 3–12 months |
| Best suited for | Severe dependence, unsafe home environment, co-occurring disorders | Step-down from inpatient, moderate severity, stable housing | Working adults, early-stage dependency, strong support network | Mild dependency, maintenance phase, high-functioning |
| Medical supervision | 24/7 on-site physicians | Daily medical check-ins | Weekly psychiatric oversight | As-needed basis |
| Avg. cost (30 days) | $6,000 – $60,000 | $3,500 – $18,000 | $1,400 – $10,000 | $1,000 – $5,000 |
| Insurance coverage | Most plans, 60+ days under Parity Act | Widely covered, pre-auth often required | Broadly covered, lower co-pays | Typically covered, minimal barriers |
| Disruption to daily life | High — full pause on work, family | Moderate — evenings and weekends free | Low–moderate — flexible scheduling | Minimal — fits around existing schedule |
| 12-month sobriety rate | 35–65% (severity-adjusted) | 40–60% | 30–50% | 20–35% |
“Medication-assisted treatment isn’t replacing one addiction with another. It’s treating a brain disease with medicine — the same way we treat diabetes with insulin.”
American Society of Addiction Medicine
Your brain's opioid receptors don't care about stigma. These are the four main pharmacological approaches, compared on the evidence that actually matters — not the assumptions that follow these medications around.
| Category | MethadoneDaily clinic dosing | BuprenorphineSuboxone / Subutex | NaltrexoneVivitrol / ReVia | Abstinence onlyNo medication |
|---|---|---|---|---|
| How it works | Full opioid agonist — eliminates withdrawal and cravings by occupying receptors | Partial agonist — reduces cravings with a ceiling effect that limits misuse potential | Opioid antagonist — blocks all opioid effects, requires full detox first | Behavioral therapy only, no pharmacological support |
| Reduces overdose death | ↓ 50% | ↓ 38% | ↓ 36% | No reduction |
| Typical duration | Indefinite (maintenance) — years to lifetime | 1–3 years average; some use indefinitely | 6–12 months; monthly injection available | N/A |
| Requires full detox first | No | Partial (12–24 hrs abstinence) | Yes — 7–10 days fully opioid-free | Yes |
| Access | Federally licensed clinics only — daily in-person dosing initially | Any certified physician, telehealth available since 2023 | Any licensed prescriber, no special certification | No prescription needed |
| Common side effects | Sedation, constipation, QT prolongation (cardiac monitoring required) | Mild: headache, constipation, insomnia — generally well tolerated | Nausea (first weeks), injection site reactions, hepatotoxicity risk at high doses | Withdrawal symptoms, higher relapse risk |
| Your brain chemistry | Normalizes dopamine response over months; prevents withdrawal spikes | Stabilizes receptor activity; partial activation prevents severe withdrawal | Blocks reward pathway entirely; no physical dependence possible | Receptors remain sensitized — cravings are neurological, not willpower |
There is no single right way to recover. The evidence supports multiple frameworks — and the best one is the one you'll actually stay with. Here's what each approach actually asks of you.
| Category | 12-Step ProgramsAA / NA / CA | SMART RecoveryScience-based, secular | Harm ReductionModeration-inclusive | Contingency ManagementIncentive-based |
|---|---|---|---|---|
| Core philosophy | Spiritual framework; surrender to higher power; lifelong identity as person in recovery | Cognitive-behavioral; self-empowerment; tools not steps; no higher power required | Reduce harm first; abstinence is one option not the only one; meet people where they are | Positive reinforcement; tangible rewards for negative drug tests; behavioral conditioning |
| Evidence base | Moderate — large observational studies; RCT evidence limited by anonymity constraints | Strong — CBT foundation with 30+ years of RCT support | Growing — strong for opioids; robust evidence for needle exchange and supervised consumption | Strong — highest RCT evidence of any behavioral intervention |
| Meeting frequency | Daily recommended initially; 90 meetings in 90 days common | 1–2 per week; online meetings widely available | Variable — program-dependent; drop-in models common | Tied to treatment schedule — typically 3x/week initially |
| Abstinence required | Yes — complete abstinence; MAT use is contested in some groups | Goal-dependent — abstinence preferred but harm reduction accepted | No — reduction goals are valid treatment outcomes | Yes for incentive rewards; typically tied to specific substance |
| Best fit for | People who find meaning in community and spiritual frameworks; alcohol and stimulant use disorders | Secular individuals; those who prefer tools over steps; co-occurring anxiety or depression | People not ready for abstinence; polysubstance use; housing instability | Stimulant use disorder (no MAT exists); early recovery reinforcement; adolescents |
| Cost | Free — voluntary donations only | Free meetings; workbooks $10–$25 | Free to low-cost; many services are public health funded | Covered through treatment programs; incentives typically $10–$30/visit |
Honest answers to the questions that come at 2 a.m. — about cost, relapse, and what “recovery” actually looks like in practice.
Inpatient rehab ranges from $6,000–$60,000 for 30 days. Outpatient programs run $1,400–$10,000 for 90 days. Medicaid covers MAT in all 50 states. Most private insurance covers at least 60 days of residential treatment under the Mental Health Parity Act.
Relapse is part of the clinical picture for roughly 40–60% of people with substance use disorder — the same rate as hypertension and asthma. It is not a moral failure. It is a signal to adjust your treatment plan, not abandon it.
NIDA guidelines recommend at least 90 days of treatment for meaningful outcomes. Detox alone — typically 3–10 days — addresses physical dependence only. Sustained recovery is measured in months and years, not weeks.
No. This is one of the most persistent myths in addiction medicine. Buprenorphine and methadone stabilize brain chemistry without producing the euphoria cycle of misuse. The American Society of Addiction Medicine and every major medical body endorse MAT as first-line treatment.
The average person requires 4–5 treatment episodes before sustained sobriety. Treatment "failure" often reflects treatment fit, not personal failure. Different modalities, medication adjustments, and timing all affect outcomes significantly.
A five-minute, free assessment that maps your specific situation — substance, timeline, support structure, insurance — onto the treatment options most likely to work for you.
No account. No email. No commitment. Just clarity.